Home
Live Updates
CARsgens Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting : comparemela.com
CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting
/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of...
Related Keywords
United States ,
China ,
Shanghai ,
American ,
America ,
Raffaele Baffa ,
Carsgen Therapeutics Holdings Limited Stock Code ,
Carsgen Therapeutics Holdings ,
Therapeutics Holdings Limited ,
Stock Code ,
Chief Medical Officer ,
Antigen Receptort Cell Therapy ,
Advanced Gastric ,
Pancreatic Adenocarcinoma ,
Recommended Phase ,
Response Rate ,
Clinical Benefit Rate ,
North America ,
Regenerative Medicine Advanced Therapy ,
Orphan Drug ,
Orphan Medicinal Product ,
Therapeutics Holdings ,
Carsgen Therapeutics ,
comparemela.com © 2020. All Rights Reserved.